Carbetocin versus Oxytocin for the Prevention of Postpartum Hemorrhage in Gestational Diabetic Women Undergoing Cesarean Section

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201909768132154

Enrollment

160

Registered

2019-09-19

Start date

2015-04-20

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

oxytocin group

carbetocin group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: women aged 18-35 years with term singleton pregnancy prepared for elective lower segment CS at gestational age of = 37 weeks with diagnosed gestational diabetes.

Exclusion criteria

Exclusion criteria: Women with anticipated excessive blood loss during surgery, i.e. placenta previa, twin pregnancy or presence of uterine fibroid women with history of bleeding disorders cases suffering from chronic medical diseases (cardiac, hepatic, renal).

Design outcomes

Primary

Measure	Time frame
•Estimated amount of blood loss.	—

Secondary

Measure	Time frame
need for blood transfusion, additional uterotonics, drug-related side effects	—

Countries

Egypt

Contacts

Public Contactomima taha

suez canal university

omimatharwat@yahoo.com01223423685

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026